Medical authorities are struggling with shortages of essential medicines due to a global drug supply crisis, highlighting the flaws in the profit-oriented pharmaceutical system.
The growing threat of drug-resistant superbugs and antimicrobial resistance crisis could surpass the impact of the COVID-19 pandemic without urgent action, including new antibiotics development.
Collection
[
|
...
]